Market Cap 10.46B
Revenue (ttm) 12.82B
Net Income (ttm) 936.34M
EPS (ttm) N/A
PE Ratio 14.90
Forward PE 13.05
Profit Margin 7.31%
Debt to Equity Ratio -1,501.73
Volume 897,100
Avg Vol 784,070
Day's Range N/A - N/A
Shares Out 75.50M
Stochastic %K 18%
Beta 1.09
Analysts Sell
Price Target $162.28

Company Profile

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative se...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 720-631-2100
Address:
2000 16th Street, Denver, United States
OpenOutcrier
OpenOutcrier Aug. 5 at 12:05 PM
$SIRI $DVA $BRK/B Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita https://ooc.bz/l/72512
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 4:04 AM
Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings $DVA https://stocktwits.com/news/equity/markets/warren-buffett-s-berkshire-hathaway-offloads-230-m-of-this-dialysis-service-provider-ahead-of-its-q2-earnings/chrLWITRdcQ
0 · Reply
Noname2022
Noname2022 Aug. 1 at 3:32 PM
1 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 5:53 PM
$DVA set for a potential earnings beat — should you add before the report? 🚀 📈 Positive Earnings ESP of +6.67% + Zacks Rank #3 = strong beat potential 💊 CMS transition of phosphate binders, with reimbursements from CMS and Medicare Advantage, could boost revenues See why DaVita could be a wise addition here 👉 https://www.zacks.com/stock/news/2644950/can-phosphate-binders-drive-davita-stock-before-q2-earnings?cid=sm-stocktwits-2-2644950-body-5234&ADID=SYND_STOCKTWITS_TWEET_2_2644950_BODY_5234
0 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 4:45 PM
$DVA riding a quiet tailwind into Q2 earnings — but will it last? Early momentum from phosphate binders looks promising, yet peritoneal dialysis supply issues could muddy the outlook. Full breakdown before the print 👉 https://www.zacks.com/stock/news/2644950/can-phosphate-binders-drive-davita-stock-before-q2-earnings?cid=sm-stocktwits-2-2644950-teaser-5173&ADID=SYND_STOCKTWITS_TWEET_2_2644950_TEASER_5173
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 30 at 3:43 PM
$DVA Excellent article that nails exactly where DVA stands right now. So if you want to update your DVA knowledge or get acquainted with DVA, this is a must read. https://beyondspx.com/article/davita-s-kidney-care-ecosystem-margin-strength-and-strategic-growth-nyse-dva
0 · Reply
wolverine
wolverine Jul. 30 at 2:19 PM
$CRMD we know $FMS is on board could the latest raise be for $DVA also coming on board? Seems criminal for Davita to not continue to offer a product that dramatically reduces infections when they admitted deaths were an issue on one of their last calls.
2 · Reply
Noname2022
Noname2022 Jul. 24 at 3:03 PM
$CRMD $FMS $DVA $CTXR The more you know: CLABSI - epidemiological definition CBRSI - clinical diagnosis Dialysis patients are: ~1% of federal budget spend ~7% of medicare spending
0 · Reply
Noname2022
Noname2022 Jul. 23 at 7:13 PM
3 · Reply
NightBreeze
NightBreeze Jul. 22 at 9:26 PM
$DVA I love big gaps and I cannot lie
0 · Reply
Latest News on DVA
DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call

Jul 17, 2025, 5:37 PM EDT - 18 days ago

DaVita Inc. Schedules 2nd Quarter 2025 Investor Conference Call


DaVita: International Expansion And Buybacks Will Boost Returns

May 27, 2025, 11:30 AM EDT - 2 months ago

DaVita: International Expansion And Buybacks Will Boost Returns


DaVita Inc. Announces Offering of $750 Million Senior Notes

May 20, 2025, 8:51 AM EDT - 2 months ago

DaVita Inc. Announces Offering of $750 Million Senior Notes


DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript

May 12, 2025, 9:41 PM EDT - 3 months ago

DaVita Inc. (DVA) Q1 2025 Earnings Call Transcript


DaVita First-Quarter 2025 Financial Results: Just the Numbers

May 12, 2025, 4:51 PM EDT - 3 months ago

DaVita First-Quarter 2025 Financial Results: Just the Numbers


DaVita Inc. 1st Quarter 2025 Results

May 12, 2025, 4:05 PM EDT - 3 months ago

DaVita Inc. 1st Quarter 2025 Results


DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call

Apr 30, 2025, 11:00 AM EDT - 3 months ago

DaVita Inc. Schedules 1st Quarter 2025 Investor Conference Call


DaVita Says Ransomware Attack Affecting Some Operations

Apr 14, 2025, 7:35 AM EDT - 4 months ago

DaVita Says Ransomware Attack Affecting Some Operations


Dialysis firm DaVita hit by ransomware attack

Apr 14, 2025, 7:33 AM EDT - 4 months ago

Dialysis firm DaVita hit by ransomware attack


Berkshire Hathaway sells another 750,000 DaVita shares

Feb 19, 2025, 8:05 PM EST - 5 months ago

Berkshire Hathaway sells another 750,000 DaVita shares


DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 8:19 PM EST - 6 months ago

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript


Berkshire sells some DaVita shares, cuts stake to 45%

Feb 13, 2025, 8:13 PM EST - 6 months ago

Berkshire sells some DaVita shares, cuts stake to 45%


DaVita forecasts 2025 profit below estimates, shares plummet

Feb 13, 2025, 6:07 PM EST - 6 months ago

DaVita forecasts 2025 profit below estimates, shares plummet


DaVita Inc. 4th Quarter 2024 Results

Feb 13, 2025, 4:05 PM EST - 6 months ago

DaVita Inc. 4th Quarter 2024 Results


DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call

Jan 30, 2025, 11:55 AM EST - 6 months ago

DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call


DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 9:27 PM EDT - 9 months ago

DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript


DaVita misses third-quarter profit estimates on higher costs

Oct 29, 2024, 4:23 PM EDT - 9 months ago

DaVita misses third-quarter profit estimates on higher costs


DaVita Inc. 3rd Quarter 2024 Results

Oct 29, 2024, 4:05 PM EDT - 9 months ago

DaVita Inc. 3rd Quarter 2024 Results


DaVita Appoints Jessica Hergenreter as Chief People Officer

Oct 17, 2024, 1:00 PM EDT - 10 months ago

DaVita Appoints Jessica Hergenreter as Chief People Officer


DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call

Oct 9, 2024, 1:47 PM EDT - 10 months ago

DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call


Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

Aug 30, 2024, 8:00 AM EDT - 1 year ago

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

DUK JNJ


DaVita Inc. Announces Offering of $1.0 Billion Senior Notes

Aug 8, 2024, 9:16 AM EDT - 1 year ago

DaVita Inc. Announces Offering of $1.0 Billion Senior Notes


DaVita Inc. 2nd Quarter 2024 Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

DaVita Inc. 2nd Quarter 2024 Results


OpenOutcrier
OpenOutcrier Aug. 5 at 12:05 PM
$SIRI $DVA $BRK/B Berkshire Hathaway buys $106.5M in Sirius XM, cuts $230M in DaVita https://ooc.bz/l/72512
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 5 at 4:04 AM
Warren Buffett's Berkshire Hathaway Offloads $230M Of This Dialysis Service Provider Ahead Of Its Q2 Earnings $DVA https://stocktwits.com/news/equity/markets/warren-buffett-s-berkshire-hathaway-offloads-230-m-of-this-dialysis-service-provider-ahead-of-its-q2-earnings/chrLWITRdcQ
0 · Reply
Noname2022
Noname2022 Aug. 1 at 3:32 PM
1 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 5:53 PM
$DVA set for a potential earnings beat — should you add before the report? 🚀 📈 Positive Earnings ESP of +6.67% + Zacks Rank #3 = strong beat potential 💊 CMS transition of phosphate binders, with reimbursements from CMS and Medicare Advantage, could boost revenues See why DaVita could be a wise addition here 👉 https://www.zacks.com/stock/news/2644950/can-phosphate-binders-drive-davita-stock-before-q2-earnings?cid=sm-stocktwits-2-2644950-body-5234&ADID=SYND_STOCKTWITS_TWEET_2_2644950_BODY_5234
0 · Reply
ZacksResearch
ZacksResearch Jul. 31 at 4:45 PM
$DVA riding a quiet tailwind into Q2 earnings — but will it last? Early momentum from phosphate binders looks promising, yet peritoneal dialysis supply issues could muddy the outlook. Full breakdown before the print 👉 https://www.zacks.com/stock/news/2644950/can-phosphate-binders-drive-davita-stock-before-q2-earnings?cid=sm-stocktwits-2-2644950-teaser-5173&ADID=SYND_STOCKTWITS_TWEET_2_2644950_TEASER_5173
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 30 at 3:43 PM
$DVA Excellent article that nails exactly where DVA stands right now. So if you want to update your DVA knowledge or get acquainted with DVA, this is a must read. https://beyondspx.com/article/davita-s-kidney-care-ecosystem-margin-strength-and-strategic-growth-nyse-dva
0 · Reply
wolverine
wolverine Jul. 30 at 2:19 PM
$CRMD we know $FMS is on board could the latest raise be for $DVA also coming on board? Seems criminal for Davita to not continue to offer a product that dramatically reduces infections when they admitted deaths were an issue on one of their last calls.
2 · Reply
Noname2022
Noname2022 Jul. 24 at 3:03 PM
$CRMD $FMS $DVA $CTXR The more you know: CLABSI - epidemiological definition CBRSI - clinical diagnosis Dialysis patients are: ~1% of federal budget spend ~7% of medicare spending
0 · Reply
Noname2022
Noname2022 Jul. 23 at 7:13 PM
3 · Reply
NightBreeze
NightBreeze Jul. 22 at 9:26 PM
$DVA I love big gaps and I cannot lie
0 · Reply
Noname2022
Noname2022 Jul. 18 at 6:01 PM
$CRMD $DVA Infection and mortality rates matter. Curious if DaVita’s ready to follow where others are leading on CLABSI prevention.
2 · Reply
Noname2022
Noname2022 Jul. 11 at 3:40 AM
4 · Reply
Noname2022
Noname2022 Jul. 10 at 1:16 AM
1 · Reply
theoptionsplug
theoptionsplug Jul. 4 at 6:54 PM
$DVA DaVita Daily Chart 🏥 - On May 27th, Berkshire $BRK.A / $BRK.B acquired a 44.8% stake in the company (a $4,818,034,885 position) - Looks good to dabble on here as price pulls back to its 50 DMA. I like shares over trading options on it...
1 · Reply
SparkyReturns
SparkyReturns Jun. 24 at 3:33 PM
$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS
0 · Reply
IntensiveCareUnit
IntensiveCareUnit Jun. 23 at 6:26 PM
$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.
1 · Reply
Ryant19
Ryant19 Jun. 23 at 3:26 PM
$CRMD Too bad $DVA is in bed with $ICUI. Turning a blind eye to patient safety due to back room deals
1 · Reply
Thewonderyears
Thewonderyears Jun. 16 at 8:56 AM
$DVA Government Contract Update: $206M payment to DAVITA INC
0 · Reply
DonCorleone77
DonCorleone77 May. 30 at 8:05 PM
$DVA DaVita 'applauds' CMMI decision to extend Kidney Care Choices Model DaVita issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation related to its Kidney Care Choices Model. Misha Palecek, Chief Transformation Officer for DaVita, said: "As a dedicated participant in the government's value-based care initiative and a pioneer in this field for the last twenty years, we applaud CMMI's decision to extend the Kidney Care Choices Model for an additional year. We believe the investments made by CMMI and participants alike will result in long-term savings in the upcoming years. The program's emphasis on comprehensive, collaborative care and patient engagement is driving encouraging health outcomes. DaVita is committed to establishing a new standard for kidney care through integrated care systems alongside our nephrology partners."
0 · Reply
Mallingan
Mallingan May. 29 at 12:38 PM
0 · Reply
AlertsAndNews
AlertsAndNews May. 28 at 2:53 AM
$DVA $BRK.A $BRK.B DaVita Buffett selling some. Warren E. Buffett (10%+ owner) sells 200,000 shares at an average price of $138.85. Still has 33M+ shares.
0 · Reply
Mallingan
Mallingan May. 26 at 10:41 AM
$DVA https://www.ibtimes.co.uk/warren-buffett-sells-168m-davita-shares-one-day-before-dialysis-provider-hit-lawsuit-1733814
0 · Reply